Applied Genetic Technologies Corporation AGTC was a big mover last session, as the company saw its shares shoot up over 15% on the day. This significant rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 22.55% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Applied Genetic Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Actelion Ltd. (ALIOF) and Enzo Biochem Inc. ENZ carrying a Zacks Rank #1 (Strong Buy) and Amicus Therapeutics, Inc. FOLD with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
APPLIED GEN TEC AGTC: Free Stock Analysis Report
ACTELION LTD (ALIOF): Get Free Report
ENZO BIOCHEM ENZ: Get Free Report
AMICUS THERAPT FOLD: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
